These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
462 related articles for article (PubMed ID: 34326372)
1. Epigenetic regulation of triple negative breast cancer (TNBC) by TGF-β signaling. Vishnubalaji R; Alajez NM Sci Rep; 2021 Jul; 11(1):15410. PubMed ID: 34326372 [TBL] [Abstract][Full Text] [Related]
2. Formononetin relieves the facilitating effect of lncRNA AFAP1-AS1-miR-195/miR-545 axis on progression and chemo-resistance of triple-negative breast cancer. Wu J; Xu W; Ma L; Sheng J; Ye M; Chen H; Zhang Y; Wang B; Liao M; Meng T; Zhou Y; Chen H Aging (Albany NY); 2021 Jul; 13(14):18191-18222. PubMed ID: 34289449 [TBL] [Abstract][Full Text] [Related]
3. LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis. Wang R; Huang Z; Qian C; Wang M; Zheng Y; Jiang R; Yu C Biochem Biophys Res Commun; 2020 Jun; 526(4):1005-1012. PubMed ID: 32307083 [TBL] [Abstract][Full Text] [Related]
4. POU2F2-mediated upregulation of lncRNA Li J; Li PT; Wu W; Ding BN; Wen YG; Cai HL; Liu SX; Hong T; Zhang JF; Zhou JD; Qian LY; Du J Epigenomics; 2024 Feb; 16(4):215-231. PubMed ID: 38318853 [TBL] [Abstract][Full Text] [Related]
5. LncRNA FAM83H-AS1 promotes triple-negative breast cancer progression by regulating the miR-136-5p/metadherin axis. Han C; Fu Y; Zeng N; Yin J; Li Q Aging (Albany NY); 2020 Feb; 12(4):3594-3616. PubMed ID: 32074085 [TBL] [Abstract][Full Text] [Related]
6. A novel tumor suppressor ASMTL-AS1 regulates the miR-1228-3p/SOX17/β-catenin axis in triple-negative breast cancer. Sun J; Li X; Yu E; Liu J; Sun L; He Q; Lu Q Diagn Pathol; 2021 May; 16(1):45. PubMed ID: 34006305 [TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA ZEB2-AS1 promotes the proliferation, metastasis and epithelial mesenchymal transition in triple-negative breast cancer by epigenetically activating ZEB2. Zhang G; Li H; Sun R; Li P; Yang Z; Liu Y; Wang Z; Yang Y; Yin C J Cell Mol Med; 2019 May; 23(5):3271-3279. PubMed ID: 30825262 [TBL] [Abstract][Full Text] [Related]
8. Knockdown of long non-coding RNA TP73-AS1 suppresses triple negative breast cancer cell vasculogenic mimicry by targeting miR-490-3p/TWIST1 axis. Tao W; Sun W; Zhu H; Zhang J Biochem Biophys Res Commun; 2018 Oct; 504(4):629-634. PubMed ID: 30193732 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway. Chen Y; Gao H; Li Y Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422 [TBL] [Abstract][Full Text] [Related]
10. LncRNA PRKCQ-AS1 regulates paclitaxel resistance in triple-negative breast cancer cells through miR-361-5p/PIK3C3 mediated autophagy. Zheng S; Fu W; Huang Q; Zhou J; Lu K; Gu J; Ma R; Guo G Clin Exp Pharmacol Physiol; 2023 Jun; 50(6):431-442. PubMed ID: 36732923 [TBL] [Abstract][Full Text] [Related]
11. ZEB1 induced-upregulation of long noncoding RNA ZEB1-AS1 facilitates the progression of triple negative breast cancer by binding with ELAVL1 to maintain the stability of ZEB1 mRNA. Luo N; Zhang K; Li X; Hu Y J Cell Biochem; 2020 Oct; 121(10):4176-4187. PubMed ID: 31922280 [TBL] [Abstract][Full Text] [Related]
12. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448. Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489 [TBL] [Abstract][Full Text] [Related]
13. CTCF-Induced lncRNA C5orf66-AS1 Facilitates the Progression of Triple-Negative Breast Cancer via Sponging miR-149-5p to Up-Regulate CTCF and CTNNB1 to Activate Wnt/β-Catenin Pathway. Zhu S; Sun J; Liu X; Shao H; Feng C; Wang Z; Zheng X; Wei S Mol Cell Biol; 2022 Jun; 42(6):e0018821. PubMed ID: 35499320 [TBL] [Abstract][Full Text] [Related]
14. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway. Kim S; Lee J; Jeon M; Lee JE; Nam SJ Oncotarget; 2016 Jan; 7(2):1544-58. PubMed ID: 26637807 [TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA MALAT1 promotes proliferation and invasion via targeting miR-129-5p in triple-negative breast cancer. Zuo Y; Li Y; Zhou Z; Ma M; Fu K Biomed Pharmacother; 2017 Nov; 95():922-928. PubMed ID: 28915533 [TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA SOX21-AS1 regulates the progression of triple-negative breast cancer through regulation of miR-520a-5p/ORMDL3 axis. Liu X; Song J; Kang Y; Wang Y; Chen A J Cell Biochem; 2020 Nov; 121(11):4601-4611. PubMed ID: 32277517 [TBL] [Abstract][Full Text] [Related]
17. LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by sponging miR-219a-5p. Wang L; Luan T; Zhou S; Lin J; Yang Y; Liu W; Tong X; Jiang W Cancer Med; 2019 Aug; 8(9):4389-4403. PubMed ID: 31215169 [TBL] [Abstract][Full Text] [Related]
18. lncRNA AFAP1-AS1 promotes triple negative breast cancer cell proliferation and invasion via targeting miR-145 to regulate MTH1 expression. Zhang X; Zhou Y; Mao F; Lin Y; Shen S; Sun Q Sci Rep; 2020 May; 10(1):7662. PubMed ID: 32376943 [TBL] [Abstract][Full Text] [Related]
19. LncRNA HAND2-AS1 suppressed the growth of triple negative breast cancer via reducing secretion of MSCs derived exosomal miR-106a-5p. Xing L; Tang X; Wu K; Huang X; Yi Y; Huan J Aging (Albany NY); 2020 Dec; 13(1):424-436. PubMed ID: 33290256 [TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA LRRC75A-AS1 facilitates triple negative breast cancer cell proliferation and invasion via functioning as a ceRNA to modulate BAALC. Li S; Wu D; Jia H; Zhang Z Cell Death Dis; 2020 Aug; 11(8):643. PubMed ID: 32811810 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]